Published in Lancet on May 11, 2005
Topical Delivery of Vitamin D3 as Vitamin D Supplementation | NCT02735200
Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ (2010) 10.85
Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest (2005) 5.19
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ (2008) 5.14
Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int (2008) 3.48
Effect of calcium supplementation on hip fractures. Osteoporos Int (2008) 2.79
Skeletal and nonskeletal effects of vitamin D: is vitamin D a tonic for bone and other tissues? Osteoporos Int (2014) 2.74
The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev (2012) 2.71
Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ (2010) 2.67
Calcium intake and risk of fracture: systematic review. BMJ (2015) 2.60
Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int (2007) 2.56
Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res (2011) 2.55
Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr (2011) 2.44
Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med (2008) 2.44
The calcium scare--what would Austin Bradford Hill have thought? Osteoporos Int (2011) 2.35
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract (2011) 2.29
Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis. J Am Geriatr Soc (2010) 2.10
Not enough vitamin D: health consequences for Canadians. Can Fam Physician (2007) 2.03
Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative. Menopause (2010) 2.00
Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int (2008) 1.97
Cardiovascular effects of calcium supplementation. Osteoporos Int (2011) 1.96
Reports of clinical trials should begin and end with up-to-date systematic reviews of other relevant evidence: a status report. J R Soc Med (2007) 1.95
Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract (2009) 1.93
Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients (2013) 1.81
Osteoporosis in men. Endocr Rev (2008) 1.80
Benefit-risk assessment of vitamin D supplementation. Osteoporos Int (2009) 1.70
Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res (2009) 1.66
Recommendations for preventing fracture in long-term care. CMAJ (2015) 1.62
Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int (2015) 1.60
Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary). CMAJ (2010) 1.59
Strategies to improve retention in randomised trials. Cochrane Database Syst Rev (2013) 1.58
Calcium and vitamin D: skeletal and extraskeletal health. Curr Rheumatol Rep (2008) 1.54
Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat. Rheumatol Int (2009) 1.53
Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol (2009) 1.51
Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ (2010) 1.45
Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab (2012) 1.42
Role of vitamin D in adults requiring nutrition support. JPEN J Parenter Enteral Nutr (2009) 1.40
Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol (2012) 1.37
Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. J Bone Miner Res (2010) 1.35
Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures. Osteoporos Int (2008) 1.34
Canadian Consensus Conference on osteoporosis, 2006 update. J Obstet Gynaecol Can (2006) 1.33
Vitamin D and its role in skeletal muscle. Curr Opin Clin Nutr Metab Care (2009) 1.27
Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int (2008) 1.26
Should we prescribe calcium supplements for osteoporosis prevention? J Bone Metab (2014) 1.24
Simple imputation methods were inadequate for missing not at random (MNAR) quality of life data. Health Qual Life Outcomes (2008) 1.20
Low vitamin D status: definition, prevalence, consequences, and correction. Endocrinol Metab Clin North Am (2010) 1.18
Fall prevention and vitamin D in the elderly: an overview of the key role of the non-bone effects. J Neuroeng Rehabil (2010) 1.14
Effect of calcium supplementation on fracture risk: a double-blind randomized controlled trial. Am J Clin Nutr (2008) 1.12
Falls in the community-dwelling older adult: a review for primary-care providers. Clin Interv Aging (2007) 1.12
Multifactorial analysis of risk factors for reduced bone mineral density among postmenopausal women. Arch Med Sci (2012) 1.11
Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos Int (2007) 1.09
How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int (2006) 1.08
Are more trials of calcium supplements really needed? Osteoporos Int (2017) 1.08
Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies. BMC Public Health (2010) 1.07
Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study. Osteoporos Int (2007) 1.06
Proceedings of the Rank Forum on Vitamin D. Br J Nutr (2010) 1.05
The biology and pathology of vitamin D control in bone. J Cell Biochem (2010) 1.03
Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermatoendocrinol (2012) 1.02
Investigating the missing data mechanism in quality of life outcomes: a comparison of approaches. Health Qual Life Outcomes (2009) 1.01
Osteoporosis and skeletal fractures. HSS J (2006) 1.01
Alfacalcidol-supplemented raloxifene therapy has greater bone-sparing effect than raloxifene-alone therapy in postmenopausal Japanese women with osteoporosis or osteopenia. J Bone Miner Metab (2011) 0.99
Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009. Osteoporos Int (2010) 0.97
Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial). Rheumatol Int (2007) 0.97
Predictors of 25-hydroxyvitamin D status among adults in two British national surveys. Br J Nutr (2008) 0.96
Effects of balance training using a virtual-reality system in older fallers. Clin Interv Aging (2013) 0.95
A review of calcium supplements and cardiovascular disease risk. Adv Nutr (2012) 0.94
An age-related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol treatment. J Clin Endocrinol Metab (2006) 0.93
The Cochrane Collaboration: a leading role in producing reliable evidence to inform healthcare decisions in musculoskeletal trauma and disorders. Indian J Orthop (2008) 0.91
Does increased sunlight exposure work as a strategy to improve vitamin D status in the elderly: a cluster randomised controlled trial. Osteoporos Int (2011) 0.91
Errors in NOF meta-analyses of calcium and vitamin D supplements. Osteoporos Int (2016) 0.90
The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis. BMC Musculoskelet Disord (2007) 0.90
Calcium supplement intake and risk of cardiovascular disease in women. Osteoporos Int (2014) 0.90
Vitamin D: link between osteoporosis, obesity, and diabetes? Int J Mol Sci (2014) 0.90
Effects of vitamin D in the elderly population: current status and perspectives. Arch Public Health (2014) 0.90
A case study of discordant overlapping meta-analyses: vitamin d supplements and fracture. PLoS One (2014) 0.89
Re: The calcium scare: what would Austin Bradford Hill have thought? Osteoporos Int (2011) 0.89
Fracture prevention with vitamin D supplementation: considering the inconsistent results. BMC Musculoskelet Disord (2007) 0.88
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations. Endocr Pract (2011) 0.88
Bone Health in Athletes: The Role of Exercise, Nutrition, and Hormones. Sports Health (2016) 0.88
"Test me and treat me"--attitudes to vitamin D deficiency and supplementation: a qualitative study. BMJ Open (2015) 0.87
Annual feedback is an effective tool for a sustained increase in calcium intake among older women. Nutrients (2010) 0.87
The use of calcium and vitamin D in the management of osteoporosis. Ther Clin Risk Manag (2008) 0.87
Further major uncorrected errors in National Osteoporosis Foundation meta-analyses of calcium and vitamin D supplementation in fracture prevention. Osteoporos Int (2016) 0.86
Cardiovascular effects of calcium supplements. Nutrients (2013) 0.86
Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature. Osteoporos Int (2005) 0.86
The association between non-melanoma skin cancer and osteoporotic fractures--a population-based record linkage study. Osteoporos Int (2007) 0.86
Vitamin D dose response is underestimated by Endocrine Society's Clinical Practice Guideline. Endocr Connect (2013) 0.85
Calcium supplementation increases blood creatinine concentration in a randomized controlled trial. PLoS One (2014) 0.85
Erratum and additional analyses re: Calcium plus vitamin D supplementation and the risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int (2016) 0.85
Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays. Osteoporos Int (2015) 0.84
Bone and the perimenopause. Obstet Gynecol Clin North Am (2011) 0.84
Fracture prevention in postmenopausal women. BMJ Clin Evid (2011) 0.84
Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels--an observational study during clinical practice conditions. Osteoporos Int (2010) 0.83
Subgroup analysis for the risk of cardiovascular disease with calcium supplements. Bonekey Rep (2013) 0.83
Management of age-related osteoporosis and prevention of associated fractures. Ther Clin Risk Manag (2006) 0.83
Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study. Clin Interv Aging (2013) 0.83
Vitamin D supplements with or without calcium to prevent fractures. Bonekey Rep (2014) 0.83
Vitamin D insufficiency over 5 years is associated with increased fracture risk-an observational cohort study of elderly women. Osteoporos Int (2014) 0.82
Management of osteoporosis in the aging male: focus on zoledronic acid. Clin Interv Aging (2009) 0.82
Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess (2004) 29.45
What are pragmatic trials? BMJ (1998) 7.93
Interventions for preventing falls in elderly people. Cochrane Database Syst Rev (2003) 7.05
Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess (1999) 7.00
Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study. Health Technol Assess (2007) 6.55
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17
Epidemiology of fractures in England and Wales. Bone (2001) 5.76
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol (1997) 5.64
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
Perspective. How many women have osteoporosis? J Bone Miner Res (1992) 4.99
Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet (2006) 4.95
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the patellofemoral joint. Ann Rheum Dis (1992) 4.79
Use of oral corticosteroids and risk of fractures. J Bone Miner Res (2000) 4.75
Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ (1997) 4.63
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2000) 4.37
Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature (1995) 4.24
Midwife managed delivery unit: a randomised controlled comparison with consultant led care. BMJ (1994) 4.23
Patients with learning disability in the community. BMJ (1999) 4.19
Bone density screening for osteoporosis. Lancet (1990) 3.87
Defining osteoarthritis of the hip for epidemiologic studies. Am J Epidemiol (1990) 3.77
Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int (2009) 3.74
Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess (2004) 3.73
Neonatal examination and screening trial (NEST): a randomised, controlled, switchback trial of alternative policies for low risk infants. BMJ (1999) 3.63
Cohort profile: the Hertfordshire cohort study. Int J Epidemiol (2005) 3.62
A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int (2012) 3.62
Bone densitometry in clinical practice. BMJ (1995) 3.48
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int (2002) 3.45
Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res (1998) 3.44
A systematic review of discharge coding accuracy. J Public Health Med (2001) 3.36
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36
The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res (1996) 3.25
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A (2001) 3.23
Determinants of disability in osteoarthritis of the knee. Ann Rheum Dis (1993) 3.16
Fluoride in drinking water and risk of hip fracture in the UK: a case-control study. Lancet (2000) 3.16
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Knee pain and disability in the community. Br J Rheumatol (1992) 3.15
How effective is tailored print communication? Ann Behav Med (1999) 3.10
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev (2005) 3.07
Interventions for preventing falls in elderly people. Cochrane Database Syst Rev (2001) 3.06
Pectin esterification is spatially regulated both within cell walls and between developing tissues of root apices. Planta (1990) 3.03
GP job satisfaction in 1987, 1990 and 1998: lessons for the future? Fam Pract (2000) 2.99
The use of unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials (2005) 2.98
Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med (1997) 2.98
Gutter treatment for ingrowing toenails. Br Med J (1979) 2.96
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum (2003) 2.94
Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr (2007) 2.94
Extending the CONSORT statement to cluster randomized trials: for discussion. Stat Med (2001) 2.84
Paying general practitioners: shedding light on the review of health services. J R Coll Gen Pract (1989) 2.83
Epidemiology of fractures in 15,000 adults: the influence of age and gender. J Bone Joint Surg Br (1998) 2.82
Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis. Osteoporos Int (2012) 2.81
Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) (2007) 2.81
Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int (1997) 2.80
The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int (1998) 2.77
Economic notes: definitions of efficiency. BMJ (1999) 2.77
Prospective randomized controlled trial of an intramedullary nail versus dynamic screw and plate for intertrochanteric fractures of the femur. J Orthop Trauma (2001) 2.75
Oral treatments for fungal infections of the skin of the foot. Cochrane Database Syst Rev (2002) 2.75
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas (2009) 2.74
Back pain in Britain: comparison of two prevalence surveys at an interval of 10 years. BMJ (2000) 2.73
Cluster randomised trials: time for improvement. The implications of adopting a cluster design are still largely being ignored. BMJ (1998) 2.71
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
A global representation of vitamin D status in healthy populations. Arch Osteoporos (2012) 2.69
Osteoarthritis of the hip: an occupational disease in farmers. BMJ (1992) 2.69
An economic view of high compliance as a screening objective. BMJ (1994) 2.56
Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res (2000) 2.55
Occupational physical activities and osteoarthritis of the knee. Arthritis Rheum (2000) 2.54
Prostaglandins and breast cancer. Lancet (1977) 2.54
The future of health care in Canada. BMJ (2001) 2.53
Are cost of injury studies useful? Inj Prev (2000) 2.50
Manual handling activities and risk of low back pain in nurses. Occup Environ Med (1995) 2.48
Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int (2012) 2.48
Use of statins and risk of fractures. JAMA (2001) 2.47
Perforation of chronic peptic ulcers after cimetidine. Br Med J (1977) 2.46
Prospective cohort study of predictors of incident low back pain in nurses. BMJ (1997) 2.46
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Trends in admissions for hip fracture in England and Wales, 1968-85. BMJ (1990) 2.35
Risk factors for nonunion after nonoperative treatment of displaced midshaft fractures of the clavicle. J Bone Joint Surg Am (2013) 2.32
Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord (2001) 2.30
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum (2006) 2.28
How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis Rheum (2008) 2.27
Recruitment methods for screening programmes: trial of a new method within a regional osteoporosis study. BMJ (1992) 2.27
Long-term non-pharmacological weight loss interventions for adults with prediabetes. Cochrane Database Syst Rev (2005) 2.26
Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology (2012) 2.25
Influencing the national training agenda. The UK & Ireland orthopaedic eLogbook. J Bone Joint Surg Br (2005) 2.25
Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24
Dietary calcium, physical activity, and risk of hip fracture: a prospective study. BMJ (1989) 2.24
Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst Rev (2002) 2.23
A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study. Rheumatology (Oxford) (2005) 2.23
Acetabular dysplasia and hip osteoarthritis in Britain and Japan. Br J Rheumatol (1998) 2.22
Bacterial arthritis in an English health district: a 10 year review. Ann Rheum Dis (1986) 2.21